SABS — SAB BIOTHERAPEUTICS INC

Ownership history in STEMPOINT CAPITAL LP  ·  1 quarter on record

This page tracks every 13F SEC filing in which STEMPOINT CAPITAL LP reported a position in SAB BIOTHERAPEUTICS INC (SABS). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.09% (2025 Q4)
Avg. % of fund
0.09%
First filed
2025 Q4
Last filed
2025 Q4
Quarters held
1
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 INITIATED 146,558 — — 0.09% $548K $3.74
% of Fund (quarterly)    SABS price (monthly, adj. close)

Other funds also holding SABS

As of 2025 Q4 — sorted by position size

Vivo Capital, LLC 3Y 7Y 2.76% Propel Bio Management, LLC 2.08% Commodore Capital LP 3Y 1.1% CAXTON CORP 3Y 7Y 0.92% RA CAPITAL MANAGEMENT, L.P. 3Y 7Y 0.17% Sessa Capital IM, L.P. 3Y 7Y 0.15% AWM Investment Company, Inc. 3Y 7Y 0.07% PERCEPTIVE ADVISORS LLC 3Y 7Y 0.05% FIFTH LANE CAPITAL, LP 3Y 0.04% Woodline Partners LP 3Y 0.04%
← Back to STEMPOINT CAPITAL LP Holdings